INTENSITY THERAPEUTICS, INC. RESTARTS PATIENT TREATMENT IN THE RANDOMIZED, PRESURGICAL TRIPLE NEGATIVE BREAST CANCER PHASE 2 CLINICAL TRIAL (INVINCIBLE-4 STUDY)

Reuters · 1d ago

Please log in to view news